Australia markets open in 2 hours 31 minutes

ArriVent BioPharma, Inc. (AVBP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
17.99+0.63 (+3.63%)
At close: 04:00PM EDT
17.99 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4455
Avg. Estimate-1.1-0.63-3.01-2.62
Low estimate-1.58-0.77-4.48-3.09
High estimate-0.5-0.52-2.09-1.53
Year ago EPSN/AN/A-32.38-3.01
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2333
Avg. EstimateN/A1.33MN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/A4MN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings historyInvalid DateInvalid DateInvalid DateInvalid Date
Est. EPSN/AN/AN/AN/A
Actual EPSN/AN/AN/AN/A
DifferenceN/AN/AN/AN/A
Surprise %N/AN/AN/AN/A
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.1-0.63-3.01-2.62
7 days ago-1.1-0.63-3.42-2.5
30 days ago-0.79-0.54-2.85-2.36
60 days ago-0.39-0.48-2.69-2.26
90 days ago0000
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/A1N/A
Up last 30 daysN/AN/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesAVBPIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year90.70%N/AN/AN/A
Next year13.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A